Filter
442
Text search:
human
pharmaceutical
products
Featured
Recommendations
43
New Publications
103
Language
Document type
No document type
203
Studies & Reports
97
Guidelines
74
Strategic & Response Plan
27
Manuals
21
Fact sheets
8
Training Material
6
Resource Platforms
3
Situation Updates
2
Brochures
1
Countries / Regions
Kenya
23
Global
19
Ethiopia
17
South Africa
13
India
12
Ghana
10
Western and Central Europe
10
Rwanda
9
Nigeria
8
Philippines
7
Namibia
7
Africa
7
Zimbabwe
6
Eastern Europe
6
Sierra Leone
5
Uganda
5
Zambia
5
Liberia
4
Nepal
4
Malawi
4
Senegal
3
Syria
3
Tanzania
3
Bangladesh
3
Ukraine
3
Venezuela
3
Congo, Democratic Republic of
2
South Sudan
2
Sudan
2
Botswana
2
South–East Asia Region
2
Latin America and the Carribbean
2
Burkina Faso
1
Mali
1
Cameroon
1
Niger
1
Haiti
1
Pakistan
1
Jordan
1
Thailand
1
Indonesia
1
Papua New Guinea
1
Benin
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Madagascar
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Asia
1
Fiji
1
Albania
1
Timor Leste/ East Timor
1
Iran
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
169
Key Resources
33
Clinical Guidelines
32
Public Health
24
Women & Child Health
15
Pharmacy & Technologies
8
Capacity Building
4
Toolboxes
AMR
57
Pharmacy
45
COVID-19
32
TB
25
HIV
20
Mental Health
16
Rapid Response
11
Planetary Health
11
NTDs
10
Conflict
8
Global Health Education
8
Caregiver
8
NCDs
8
Disability
6
Ebola & Marburg
4
Health Financing Toolbox
4
2.0 Rapid Response
4
Zika
3
Specific Hazards
3
Natural Hazards
2
Refugee
2
Polio
1
Malaria
1
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
This guide can inform any partner that manages or supports public health supply chains. Ministries of health, technical assistance partners, or non-governmental organization (NGO) operating distribution systems can all benefit from conducting a costing exercise and can use the material presented in
...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE
...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Med J DY Patil Univ 2017;10:229-33
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b
...
